Brief: Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh As Chief Financial Officer
01/07/2024 21:07
July 1 (Reuters) - Y-mAbs Therapeutics Inc YMAB.O :
* Y-MABS APPOINTS SEASONED BIOPHARMA EXECUTIVE PETER
PFREUNDSCHUH
AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nGNX7SkPw2
Further company coverage: YMAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary